<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26843638</article-id>
<article-id pub-id-type="pmc">4737770</article-id>
<article-id pub-id-type="publisher-id">0511-15</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.0511-15.2016</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
<subj-group>
<subject>Cellular/Molecular</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Cyfip1 Regulates Presynaptic Activity during Development</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hsiao</surname>
<given-names>Kuangfu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harony-Nicolas</surname>
<given-names>Hala</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buxbaum</surname>
<given-names>Joseph D.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Bozdagi-Gunal</surname>
<given-names>Ozlem</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Benson</surname>
<given-names>Deanna L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Neuroscience, </aff>
<aff id="aff2"><sup>2</sup>Department of Psychiatry, </aff>
<aff id="aff3"><sup>3</sup>Seaver Autism Center for Treatment and Research, </aff>
<aff id="aff4"><sup>4</sup>Department of Genetics and Genomic Sciences, and </aff>
<aff id="aff5"><sup>5</sup>Friedman Brain Institute, Icahn School of Medicine and Graduate School of Biomedical Sciences at Mount Sinai, New York, New York 10029</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to either Dr. Ozlem Bozdagi-Gunal or Dr. Deanna L. Benson,
<addr-line>Icahn School of Medicine at Mount Sinai, Department of Psychiatry, One Gustave Levy Place, New York, NY 10029,</addr-line><email>ozlem.bozdagi@mssm.edu</email> or <email>deanna.benson@mssm.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: K.H., O.B.-G., and D.L.B. designed research; K.H., H.H.-N., and O.B.-G. performed research; J.D.B. contributed unpublished reagents/analytic tools; K.H., O.B.-G., and D.L.B. analyzed data; K.H., O.B.-G., and D.L.B. wrote the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>3</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>3</day>
<month>8</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>36</volume>
<issue>5</issue>
<fpage>1564</fpage>
<lpage>1576</lpage>
<history>
<date date-type="received">
<day>2</day>
<month>2</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2016 the authors 0270-6474/16/361564-13$15.00/0</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri xlink:href="zns00516001564.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Copy number variations encompassing the gene encoding Cyfip1 have been associated with a variety of human diseases, including autism and schizophrenia. Here we show that juvenile mice hemizygous for <italic>Cyfip1</italic> have altered presynaptic function, enhanced protein translation, and increased levels of F-actin. In developing hippocampus, reduced Cyfip1 levels serve to decrease paired pulse facilitation and increase miniature EPSC frequency without a change in amplitude. Higher-resolution examination shows these changes to be caused primarily by an increase in presynaptic terminal size and enhanced vesicle release probability. Short hairpin-mediated knockdown of Cyfip1 coupled with expression of mutant Cyfip1 proteins indicates that the presynaptic alterations are caused by dysregulation of the WAVE regulatory complex. Such dysregulation occurs downstream of Rac1 as acute exposure to Rac1 inhibitors rescues presynaptic responses in culture and in hippocampal slices. The data serve to highlight an early and essential role for Cyfip1 in the generation of normally functioning synapses and suggest a means by which changes in Cyfip1 levels could impact the generation of neural networks and contribute to abnormal and maladaptive behaviors.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Several developmental brain disorders have been associated with gene duplications and deletions that serve to increase or decrease levels of encoded proteins. Cyfip1 is one such protein, but the role it plays in brain development is poorly understood. We asked whether decreased Cyfip1 levels altered the function of developing synapses. The data show that synapses with reduced Cyfip1 are larger and release neurotransmitter more rapidly. These effects are due to Cyfip1's role in actin polymerization and are reversed by expression of a Cyfip1 mutant protein retaining actin regulatory function or by inhibiting Rac1. Thus, Cyfip1 has a more prominent early role regulating presynaptic activity during a stage of development when activity helps to define neural pathways.</p>
</abstract>
<kwd-group>
<kwd>15q11.2</kwd>
<kwd>F-actin</kwd>
<kwd>Sra1</kwd>
<kwd>synaptogenesis</kwd>
<kwd>WAVE1</kwd>
<kwd>WRC</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>